These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Systemic adjuvant therapy in patients with operable breast cancer].
    Author: Tashiro H, Nomura Y, Hisamatsu K.
    Journal: Rinsho Hoshasen; 1989 Apr; 34(4):443-7. PubMed ID: 2501544.
    Abstract:
    The results of adjuvant trials conducted from April, 1972 to August, 1978 showed that chemotherapy was more effective to premenopausal patients and endocrine therapy prolonged disease-free survival of postmenopausal patients compared with premenopausal ones. Preliminary analysis of randomized trial now on going suggests that endocrine therapy is best candidate for receptor-positive patients and chemotherapy for receptor-negative patients. Prognostic factors of primary breast cancer was discussed.
    [Abstract] [Full Text] [Related] [New Search]